Section Editors

  • Simon R Carding, University of Leeds
  • Lucienne Chatenoud, Hospital Necker
  • Olivier Garraud, EFS Auvergne - Loire
  • Catherine M Hawrylowicz, King's College London
  • James Li, University of Hong Kong
  • Juan Carlos Zuniga-Pflucker, University of Toronto

Executive Editor

  • Christopher Morrey, BioMed Central

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: flickr user AJC1, Creative Commons 2.0

    Immunobiotics protect against Respiratory Syncytial Virus

    Comparative studies using two Lactobacillus rhamnosus strains demonstrate that nasal administration of immunobiotics beneficially modulate immune responses in the respiratory tract and increase resistance to Respiratory Syncytial Virus challenge in mice.

    BMC Immunology 2013, 14:40
  • Image attributed to: Flickr by NIAID

    CTLA4-Ig therapy modulates T cell effector function

    Immunological study of T cell functionality in rheumatoid arthritis patients, both ACPA-positive and ACPA-negative, starting biological therapy with the co-stimulation blockade abatacept (CTLA4-Ig), supports the recently published registry study implicating ACPA seropositivity as an independent predictive factor to treatment response.

    BMC Immunology 2013, 14:34
  • Image attributed to: BMC Immunology 2013, 14:32 (Section: Immunogenetics)

    A regulatory role for microRNA in multiple sclerosis

    Genome-wide expression analyses in T-cells from multiple sclerosis (MS) patients identifies multiple differentially expressed microRNAs that affect the expression of target genes associated with the immune system, suggesting a important regulatory role for microRNA in MS.

    BMC Immunology 2013, 14:32
  • Image attributed to: Flickr by AJC1

    Effects of HCV virus co-infection on HIV patients on HAART

    Immunological and clinical chemistry tests indicate that the improvement in CD4+ cell count of HIV/Hepatitis C (HCV) co-infected subjects under highly active antiretroviral therapy (HAART) is lower than HIV mono-infected individuals but that mono-infected patients respond better to HAART.

    BMC Immunology 2013, 14:23
  • Image attributed to: Flickr by CondonAUG

    Elucidating the effects of IL-17 on neural stem cells

    Mouse neural stem cells express Interleukin-17 (IL-17) receptors and treatment with IL-17 reduces neurosphere formation, cell number, proliferation and differentiation suggesting they may play a role in inducing demyelination and blocking neuronal repair in autoimmune disease.

    BMC Immunology 2013, 14:20

Latest review

BMC Immunology 2013, 13:63

Review Highly Accessed

Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond

Olivier Garraud, Gwenoline Borhis, Gamal Badr, Séverine Degrelle, Bruno Pozzetto, Fabrice Cognasse and Yolande Richard

BMC Immunology 2013, 13:63 (29 November 2012)

RSS

Comments

View more comments

Scope

BMC Immunology is an open access journal publishing original peer-reviewed research articles in molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system as well as clinical studies and animal models of human diseases.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Immunology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcimmunol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

Section Editor's profile

Dr Ramsland

Olivier Garraud is currently Professor of Immunology at the University of Lyon (the Faculty of Medicine of Saint-Etienne). Dr Garraud graduated as a physician and was trained in haematology and infectious diseases. He pursued his early career at the Institut Pasteur in Paris where he became involved with fundamental immunology. After more than a decade at the Institut Pasteur, Dr Garraud moved back to the field of medicine and was appointed the Executive Director of one of the 14 regional settings of the National Blood Service in France. Dr Garraud is currently supervising research programs focused on non-conventional B cell biology and platelet immunology in transfusion medicine but also in pathology, especially in infectious diseases such as sepsis, HIV infection and more generally in inflammation. Read more about his research interests in his recent review article.

"BMC Immunology is devoted to publishing high quality research in various directions in this fast growing discipline. We work hard to solicit the best possible reviewers and provide you with timely feedback in order to offer high visibility to important findings in the vast field of Immunology."

Email updates

Receive periodic news and updates relating to BioMed Central straight to your inbox.

Indexed by

  • BIOSIS
  • CAS
  • DOAJ
  • Embase
  • MEDLINE
  • PubMed
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1471-2172